Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.
Alarm plus other intervention showed no clear difference in proportion of children dry at compared with other intervention (low certainty).
Alarm may leads to higher proportion of children achieving 14 consecutive dry nights by the… compared with placebo drug (low certainty).
The review found no eligible studies for this question.
The intervention showed no clear difference in death at one year (low certainty).
Pulse cyclophosphamide showed no clear difference in dialysis at end of study compared with continuous cyclophosphamide (low certainty).
Pulse cyclophosphamide showed no clear difference in remission at 6 months compared with continuous cyclophosphamide (low certainty).
Pulse cyclophosphamide may leads to higher relapse at the end of compared with continuous cyclophosphamide (low certainty).
Pulse cyclophosphamide showed no clear difference in adverse events ‐ treatment failure compared with continuous cyclophosphamide (low certainty).
Pulse cyclophosphamide showed no clear difference in serious infections compared with continuous cyclophosphamide (low certainty).
Rituximab showed no clear difference in death at 6 months compared with cyclophosphamide (moderate certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Rituximab showed no clear difference in remission at 6 months compared with cyclophosphamide (moderate certainty).
Rituximab showed no clear difference in relapse at 12 months compared with cyclophosphamide (low certainty).
Rituximab showed no clear difference in serious adverse events compared with cyclophosphamide (moderate certainty).
Rituximab showed no clear difference in serious Infections compared with cyclophosphamide (moderate certainty).
Mycophenolate mofetil showed no clear difference in death at 6 months compared with cyclophosphamide (low certainty).